Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer
NCT04831437
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Cervix Uteri Cancer
Interventions
RADIATION:
Hypofractionated EBRT
RADIATION:
Standard EBRT
Sponsor
Tehran University of Medical Sciences